(Q39869347)

15 September 2017

Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1510426

3 October 2022

1 reference

J. T. Lettieri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1510426

3 October 2022

M. C. Rogge

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1510426

3 October 2022

L. Kaiser

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1510426

3 October 2022

R. M. Echols

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1510426

3 October 2022

A. H. Heller

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1510426

3 October 2022

language of work or name

English

0 references

publication date

1 May 1992

1 reference

PMC publication ID

188820

full work available at URL

15 September 2017

https://europepmc.org/articles/PMC188820

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1510426

https://europepmc.org/articles/PMC188820?pdf=render

3 October 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1510426

Antimicrobial Agents and Chemotherapy

3 October 2022

published in

1 reference

15 September 2017

36

1 reference

15 September 2017

5

1 reference

15 September 2017

993-996

1 reference

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188820

In-vitro studies with ciprofloxacin, a new 4-quinolone compound.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188820

Pharmacokinetics of ciprofloxacin in acutely ill and convalescent elderly patients

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188820

Clinical experience with ciprofloxacin in the USA.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188820

Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188820

The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188820

Comparison of different methods for decision-making in bioequivalence assessment.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188820

Tissue penetration and metabolism of ciprofloxacin

20 August 2018

1 reference

12 December 2020

Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillin

1 reference

12 December 2020

Vitamin D toxicity complicating the treatment of senile, postmenopausal, and glucocorticoid-induced osteoporosis. Four case reports and a critical commentary on the use of vitamin D in these disorders

1 reference

12 December 2020

In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid

1 reference

12 December 2020

Multiple-dose ciprofloxacin kinetics in normal subjects

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.36.5.993

1 reference

15 September 2017

1 reference

PMC publication ID

188820

15 September 2017

1 reference

PMC publication ID

188820